Background Despite the widespread adoption of hospital at home services it is not known if these services represent an effective way to manage patients, compared with in-patient hospital care. Method A systematic review was carried out of randomized controlled trials comparing hospital at home care with acute hospital in-patient care for patients age 18 years and over, excluding those with long-term care needs, obstetric patients, and those requiring mental health services. The following databases were searched: Medline, Embase, Social Science Citation Index, CINAHL, EconLit, PsychLit, SIGLE, Medical Care supplement on economic literature, and the EPOC (Cochrane Effective Practice and Organization of Care Review Group) register. Data were extracted forthe following outcomes: mortality, clinical complications, re-admissions, costs, hospital days saved from the provision of hospital at home, discharge destination from hospital at home, functional status, psychological well-being, patient satisfaction and carer satisfaction. Data analysis and quality assessment were undertaken independently by two reviewers using a data checklist, following standard methods described by the EPOC group.
Introduction
Hospital at home is a service that provides active treatment for a limited time period in the patient's home of a condition that otherwise would require acute hospital in-patient care. Hospital at home is a popular response to the increasing demand for acute hospital beds. Cutting costs by avoiding admission to hospital, and reducing hospital length of stay are central goals of such schemes. However, it is not known if patients admitted to hospital at home have better or equivalent health outcomes compared with patients receiving in-patient hospital care. Nor is it known if the provision of hospital at home results in a reduction, or increase, in costs to the health service.
The concept of hospital at home originated with Hospitalisation a Domicile in France in 1961,' and has been implemented in a number of other countries, including the United States, 2 Canada, and the Netherlands. 3 Hospital at home schemes vary in their philosophy and focus of care. In the United Kingdom, hospital at home concentrates on providing personal, nurse-led care rather than technical services. This is in contrast to the development of home care in other countries, where hightechnology home care, such as intravenous drug administration, is well established. 4 These schemes usually have close ties with acute hospitals, and may be encouraged by the different structure of incentives in insurance-based systems of health care.
The type of patient admitted to hospital at home varies between schemes, as does the utilization of technology. Some schemes are designed to care for specific conditions, for example, home care for patients requiring long-term ventilation, 5 but more commonly schemes are designed to care for patients discharged early from hospital after specific interventions, such as orthopaedic surgery. 6 " effectiveness of managing patients in hospital at home compared with in-patient hospital care. The following hypotheses were addressed:
(1) patients admitted to hospital at home have better health outcomes than patients being managed in in-patient hospital care; (2) patients prefer being treated at home compared with hospital; (3) re-admission rates are lower for patients discharged early from hospital to hospital at home than for patients who remain in hospital and are discharged at the standard time; (4) hospital at home is a cost-effective alternative to in-patient hospital care.
Methods of the review
A single reviewer (S.S.) read all the abstracts from the citations yielded by the electronic searches to identify relevant publications. These publications were independently read by two reviewers (S.S. and S.I.) who selected studies for the review according to pre-specified inclusion criteria. Disagreements were resolved by discussion. Investigators were contacted if information was missing. The quality of eligible trials was assessed using the criteria described by the EPOC group. 11 Data extraction was completed independently by two reviewers (S.S. and S.I.) using a checklist developed by EPOC modified and amended for the purposes of this review. This checklist is published in the Cochrane Review.
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Methods
Inclusion criteria
The review includes randomized controlled trials of hospital at home schemes that admitted patients aged 18 years or over needing treatment during an acute episode of care. Studies were considered for inclusion in the review only if standardized validated instruments were used to measure subjective outcomes.
Exclusion criteria
Only studies comparing hospital at home with acute hospital in-patient care were reviewed. The following services are excluded from the review: services providing long-term care; services provided in out-patient settings or post discharge from hospital; obstetric and mental health services; and self-care by the patient in their home, for example, the self-administration of an intravenous infusion
Search strategy
The following databases were searched: Medline (1966 Medline ( -1996 using the optimally sensitive search strategy developed by the UK Cochrane Collaboration; 10 Embase (1980 10 Embase ( -1995 ; Social Science Citation Index (1992-1995); CINAHL (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) ; EconLit ; PsychLit (1987 PsychLit ( -1996 ; SIGLE (System for Information on Grey Literature) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) The reference lists of papers identified electronically were scanned and relevant papers were retrieved. Unpublished studies were obtained by contacting providers and researchers within and outside the United Kingdom known to be involved in this field. A list of contacts was developed using the existing literature and following discussion with the UK Collaborative R&D Hospital at Home Group.
Results
Electronic searching yielded a total of 1760 citations. Eightythree of these studies met the inclusion criteria and their methods were assessed by two reviewers (S.S. and S.I.). Seven of these trials were considered for inclusion in the review, and the principal investigators were contacted if there was missing information.
Two trials were excluded after discussion with the investigators because they did not compare active homebased treatment with in-patient hospital care. 13 ' 14 The remaining five trials met all the review criteria. 15 " 20 There was disagreement over one of the included trials 17 because of uncertainty about the care the control group received. This was resolved by discussion and the trial was included.
Combining the studies was judged inappropriate because of the variation in study populations, interventions and outcomes measured between the studies. The large number of measurement tools used, and the different scales adopted restricted comparisons between health outcomes. A direct comparison of costs, although planned, was not attempted because of the different methods used by each study to calculate a cost. Where possible, post-intervention mean differences have been calculated with 95 per cent confidence limits and are presented with p values. Table 1 describes the type of patients admitted to the schemes included in this review. Detailed characteristics of teams, including size and skill mix, are included in the Cochrane Review.
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Methodological qualities of included studies
All of the trials had methodological limitations. Three trials described using sealed envelopes to conceal group allocation, and two did not describe the concealment of allocation. Only one trial 16 described the power to detect a difference between the groups. Multiple outcomes were measured in all of the trials, and yet none of the trials mentioned adjustment for multiple testing and the risk of a false positive result. Altogether there were 22 outcomes measured, and there was little uniformity in the choice of patient-based outcome measures. Table 2 . The two trials which evaluated the effectiveness of hospital at home for patients discharged early from hospital after elective surgery 17 
"
19 are shown in Table 3 , and the one trial which evaluated the effectiveness of hospital at home for terminally ill ,,20 :
patients is described in Table 4 .
Discussion
There is insufficient evidence to determine the effect of hospital at home on patient outcomes, or cost to the health service. There is some evidence to suggest increased patient satisfaction with hospital at home care compared with hospital care. 17 ' 19 ' 20 This must, however, be balanced against carers' views. Carers of patients having elective surgery expressed lower levels of satisfaction with hospital at home, compared with hospital care. Although carers of patients with a terminal illness receiving hospital at home care reported greater satisfaction than those receiving hospital care, they experienced lower morale if the patient survived for more than 30 days.
None of the trials included a full economic analysis. Those trials that attempted to address the issue of cost used average costs obtained from the provider units. None of the studies provided details on the measurement and valuation of benefits, or of the volume of resources used. The one trial in the United States 20 which examined cost in some detail failed to detect a difference in overall net health costs between hospital at home and hospital care.
It is important to take into account the transitional nature of hospital at home when determining effectiveness. Ways of delivering health care services alter as the organizational boundaries of health care change. For example, two of the trials included in this review were conducted nearly 20 years ago. Both trials evaluated the early discharge of patients after elective surgery.
However, given the overall reduction in hospital length of stay, the use of day case surgery, and the introduction of minimally invasive surgery, these trials have limited relevance today.
Conclusion
This review does not support the widespread adoption of hospital at home, nor the discontinuation of existing schemes for elderly medical patients, patients who have had elective surgery, or those with a terminal illness. When the data from current trials become available it may be possible to identify groups of patients for whom this form of care would be cost effective.
Given the heterogeneity of what is included in hospital at home and the uncertainty surrounding the effects of this form of care, future research should clearly specify the type of service being provided, both at home and at hospital, and the specific patient groups. Patient health outcomes, patient and carer satisfaction, and costs should be measured, and studies should include a formal, planned economic analysis. Studies should be large enough to detect important differences and to ensure generalizability of the results.
Four randomized trials of hospital at home are currently under way in the United Kingdom, and one randomized controlled trial has been identified in New Zealand. The first results from these trials should be available during the course of 1998 (UK Collaborative Group on Research and Development of Hospital at Home, NHS Executive, North Thames). Until the results of these, and other, studies are available, it will be unclear whether hospital at home schemes represent a new direction for health service provision. Home at 6 weeks: treatment 24/29 (82 7%); control 10/25 (40%), observed difference 42 7%; p < 0.001; 95% Cl 20% to 66% Home at 12 weeks-treatment 21/29 (72%), control 11/25 (44%); observed difference 28%; p < 0.05; 95% Cl 3% to 54% Home at 1 year: treatment 17/29 (58 6%); control 10/25 (40%); observed difference 18.6%; 95% Cl -8% to 45% Residential care. At 6 weeks: treatment 0/29 (0%), control 3/25 (12%); observed difference -12%; 95% Cl -24 7% to 0.74% At 12 weeks-treatment 1/29 (3 4%), control 4/25 (16%); observed difference -12.6%; 95% Cl -28.4% to 3.28% At 1 year, treatment 2/29 (6.9%); control 8/25 (32%); observed difference -25.1 %; 95% Cl -45.6% to -4.6%
Continuing care-At 1 year: treatment 0/29 (0%); control 2/25 (8%); observed difference -8%; 95% Cl -2.6% to 18.6% •High score indicates independence. tNo p value given, insufficient data to calculate Cl. tA measure of domestic abilities, high score indicating a good outcome SA high score indicating a good outcome USeventeen-item questionnaire derived from the National Hospice Study. "Insufficient data to calculate 95% Cl. ttComparisons were made with 13 other services but these were not reported **The 95% Cl was not calculated as equal variances cannot be assumed. § §The 95% Cl was not calculated as no numbers reported.
